Interleukin-31: A novel diagnostic marker of allergic diseases

Current Allergy and Asthma Reports

Volumn 14, Issue 4, 2014, Pages

  Rabenhorst, Anja ^a   Hartmann, Karin ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Allergy; Asthma; Atopic dermatitis; Cytokine; Diagnosis; Diagnostic marker; Disease severity; IL 31; IL 31 mRNA; Immune response; Inflammation; Interleukin 31; Mast cells; Mastocytosis; Pruritus; Skin

Indexed keywords

BIOLOGICAL MARKER; CXCL1 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 31; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; IL31 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGIC RHINITIS; ANAPHYLAXIS; APOPTOSIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BASOPHIL; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; DIARRHEA; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHIL; EPIDERMOLYSIS BULLOSA; FLUSHING; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAPLOTYPE; HEADACHE; HUMAN; IMMUNOREACTIVITY; INFLAMMATORY INFILTRATE; KERATINOCYTE; MACROPHAGE; MAST CELL; MASTOCYTOSIS; MONOCYTE; MYELOPROLIFERATIVE DISORDER; NEURODERMATITIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PROTEIN BLOOD LEVEL; PRURITUS; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN ALLERGY; SKIN DISEASE; TH2 CELL; URTICARIA; BLOOD; REVIEW;

ASTHMA; BIOLOGICAL MARKERS; DERMATITIS, ATOPIC; HUMANS; INTERLEUKINS; MASTOCYTOSIS; PRURITUS;

EID: 84893170693     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-014-0423-y     Document Type: Article

References (54)

1. Dillon SR et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004;5(7):752-60. (Pubitemid 39023308)
2. .•• Cornelissen C et al. Signaling by IL-31 and functional consequences. Eur J Cell Biol. 2012;91(6-7):552-66. This review provides an excellent summary of IL-31 structure and function.
3. Chen Q, Carroll HP, Gadina M. The newest interleukins: recent additions to the ever-growing cytokine family. Vitam Horm. 2006;74:207-28.
4. Zhang Q et al. Structures and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev. 2008;19(5-6):347-56.
5. Andoh A et al. Mucosal cytokine network in inflammatory bowel disease. World J Gastroenterol. 2008;14(33):5154-61.
6. Yagi Y et al. Interleukin-31 stimulates production of inflammatory mediators from human colonic subepithelial myofibroblasts. Int J Mol Med. 2007;19(6):941-6.
7. .• Baumann, R., et al., The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms. Clin Transl Allergy, 2012. 2(1): p. 2045-7022. This paper shows that IL-31 is not only important in the skin; after nasal challenge it is released into nasal secretions in patients with allergic rhinitis
8. Sonkoly E et al. IL-31: A new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006;117(2):411-7. (Pubitemid 43192023)
9. Schulz F et al. A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. J Allergy Clin Immunol. 2007;120(5):1097-102. (Pubitemid 350029903)
10. Nagy N et al. Common IL-31 gene haplotype associated with non-atopic eczema is not implicated in epidermolysis bullosa pruriginosa. Acta Derm Venereol. 2010;90(6):631-2.
11. Lan C-CE et al. Distinct SPINK5 and IL-31 polymorphisms are associated with atopic eczema and non-atopic hand dermatitis in Taiwanese nursing population. Exp Dermatol. 2011;20(12):975-9.
12. Yu JI et al. Identifying Polymorphisms in IL-31 and Their Association with Susceptibility to Asthma. Korean J Pathol. 2012;46(2):162-8.
13. Sokolowska-Wojdylo M et al. Association of distinct IL-31 polymorphisms with pruritus and severity of atopic dermatitis. J Eur Acad Dermatol Venereol. 2013;27(5):662-4.
14. Bilsborough J et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol. 2006;117(2):418-25. (Pubitemid 43190155)
15. Cheung PF et al. Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis. Int Immunol. 2010;22(6):453-67.
16. Wong CK et al. Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis. PLoS ONE. 2012;7(1):17.
17. Cornelissen C et al. Ultraviolet B radiation and reactive oxygen species modulate interleukin-31 expression in T lymphocytes, monocytes and dendritic cells. Br J Dermatol. 2011;165(5):966-75.
18. Kasraie S et al. Functional effects of interleukin 31 in human primary keratinocytes. Allergy. 2011;66(7):845-52.
19. Stott B et al. Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J Allergy Clin Immunol. 2013;132(2):446-54.
20. Kasraie S, Niebuhr M, Werfel T. Interleukin (IL)-31 induces proinflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins. Allergy. 2010;65(6):712-21.
21. Kasraie S, Niebuhr M, Werfel T. Interleukin (IL)-31 activates signal transducer and activator of transcription (STAT)-1, STAT-5 and extracellular signal-regulated kinase 1/2 and down-regulates IL-12p40 production in activated human macrophages. Allergy. 2013;68(6):739-47.
22. Ishii T et al. Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders. Blood. 2009;113(23):5942-50.
23. Niyonsaba F et al. Antimicrobial Peptides Human β-Defensins and Cathelicidin LL-37 Induce the Secretion of a Pruritogenic Cytokine IL-31 by Human Mast Cells. J Immunol. 2010;184(7):3526-34.
24. Escribano L et al. Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol. 2009;124(3):514-21.
25. Frieri M, Patel R, Celestin J. Mast cell activation syndrome: a review. Curr Allergy Asthma Rep. 2013;13(1):27-32.
26. Frieri M, Quershi M. Pediatric Mastocytosis: A Review of the Literature. Pediatr Allergy Immunol Pulmonol. 2013;26(4):175-80.
27. .•• Hartmann, K., et al., Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients. J Allergy Clin Immunol, 2013. 132(1): p. 232-235.e4. This study is the first to describe altered serum levels of IL-31 in patients with mastocytosis.
28. Lee CH, Yu HS. Biomarkers for itch and disease severity in atopic dermatitis. Curr Probl Dermatol. 2011;41:136-48.
29. Neis MM et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol. 2006;118(4):930-7. (Pubitemid 44498762)
30. Raap U et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol. 2008;122(2):421-3.
31. Incorvaia C et al. Allergy and the skin. Clin Exp Immunol. 2008;1:27-9. (Pubitemid 352020380)
32. Kim S et al. IL-31 Serum Protein and Tissue mRNA Levels in Patients with Atopic Dermatitis. Ann Dermatol. 2011;23(4):468-73.
33. Niebuhr M et al. Staphylococcal alpha-toxin induces a higher Tcell proliferation and interleukin-31 in atopic dermatitis. Int Arch Allergy Immunol. 2011;156(4):412-5.
34. Ezzat MH, Hasan ZE, Shaheen KY. Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring. J Eur Acad Dermatol Venereol. 2011;25(3):334-9.
35. Nobbe S et al. IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis. Acta Derm Venereol. 2012;92(1):24-8.
36. Szegedi K et al. Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Exp Dermatol. 2012;21(6):431-6.
37. .•• Hawro, T., et al., Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge. Allergy, 2013. 20(10): p. 12316. This article nicely shows that IL-31 does not induce an immediate itch response in humans.
38. •Ohmatsu, H., et al., Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma. Acta Derm Venereol, 2012. 92(3): p. 282-3. An excellent study providing new insights into the role of IL-31 in cutaneous T-cell lymphoma.
39. Takaoka A et al. Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. Eur J Pharmacol. 2005;516(2):180-1. (Pubitemid 40799355)
40. Singer EM et al. IL-31 Is Produced by the Malignant T-Cell Population in Cutaneous T-Cell Lymphoma and Correlates with CTCL Pruritus. J Invest Dermatol. 2013;133(12):2783-5.
41. Raap U et al. Increased levels of serum IL-31 in chronic spontaneous urticaria. Exp Dermatol. 2010;19(5):464-6.
42. Narbutt J et al. Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients. Arch Dermatol Res. 2013;305(3):191-5.
43. Zhang M et al. Serum levels of cytokines in systemic lupus erythematosus : Association study in a Chinese population. Z Rheumatol. 2013;7:1-4.
44. Park K et al. Increased expression of mRNAs for IL-4, IL-17, IL-22 and IL-31 in skin lesions of subacute and chronic forms of prurigo. Eur J Dermatol. 2011;21(1):135-6.
45. Shiao YMet al.MCP-1 as an effector of IL-31 signaling in familial primary cutaneous amyloidosis. J Invest Dermatol. 2013;133(5): 1375-8.
46. Cornelissen C et al. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. J Allergy Clin Immunol. 2012;129(2):426-33.
47. Grimstad Ø et al. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Ngamice: amodel of atopic dermatitis. Exp Dermatol. 2009;18(1):35-43.
48. Shah SA et al. Effects of interleukin-31 on MUC5AC gene expression in nasal allergic inflammation. Pharmacology. 2013;91(3-4):158-64.
49. Okano M et al. Characterization of pollen antigen-induced IL-31 production by PBMCs in patients with allergic rhinitis. J Allergy Clin Immunol. 2011;127(1):277-9.
50. Lei Z et al. SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma. Allergy. 2008;63(3):327-32. (Pubitemid 351224674)
51. Ip WK et al. Interleukin-31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen-activated protein kinase signalling pathways: implications for the allergic response. Immunology. 2007;122(4):532-41. (Pubitemid 350075949)
52. Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483-94.
53. .• Arai, I., et al., A single dose of interleukin-31 (IL-31) causes continuous itch-associated scratching behaviour in mice. Exp Dermatol, 2013. 22(10): p. 669-71. Interesting murine study about IL-31-induced itch-associated scratching behavior.
54. Gonzales AJ et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol. 2013;24(1):48-53.